{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:22:31Z","timestamp":1790716951761,"version":"4.1.0"},"reference-count":261,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015872","name":"Universit\u00e9 de Lille","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015872","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.autrev.2023.103486","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T07:08:05Z","timestamp":1701328085000},"page":"103486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["From ASCA breakthrough in Crohn's disease and Candida albicans research to thirty years of investigations about their meaning in human health"],"prefix":"10.1016","volume":"23","author":[{"given":"Boualem","family":"Sendid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie","family":"Cornu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Cordier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bouckaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Frederic","family":"Colombel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Poulain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2023.103486_bb0005","series-title":"94th Annual Meeting of the American Gastroenterological Association, Boston, Massachusetts, May 15\u201321,1993. Gastroenterology","first-page":"779A","article-title":"Antibodies to Saccharomyces uvarum\u202f: A specific marker of Crohn\u2019s disease?","volume":"vol. 104","author":"Sendid","year":"1993"},{"key":"10.1016\/j.autrev.2023.103486_bb0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1128\/cdli.3.2.219-226.1996","article-title":"Specific antibody response to oligomannosidic epitopes in Crohn\u2019s disease","volume":"3","author":"Sendid","year":"1996","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.autrev.2023.103486_bb0015","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/gut.42.6.788","article-title":"Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role","volume":"42","author":"Quinton","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2023.103486_bb0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1574-6968.1992.tb04997.x","article-title":"Antigenic heterogeneity of strains of Saccharomyces cerevisiae and Candida albicans recognised by serum antibodies from patients with Crohn\u2019s disease","volume":"4","author":"McKenzie","year":"1992","journal-title":"FEMS Microbiol Immunol"},{"key":"10.1016\/j.autrev.2023.103486_bb0025","first-page":"44","article-title":"Diagnostic approach to IBD","volume":"47","author":"Vermeire","year":"2000","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.autrev.2023.103486_bb0030","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011772","article-title":"Diagnostic utility of serological biomarkers in patients with Crohn\u2019s disease: a case-control study","volume":"97","author":"Yao","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2023.103486_bb0035","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1155\/2011\/712350","article-title":"Assessing inflammatory bowel disease-associated antibodies in Caucasian and First Nations cohorts","volume":"25","author":"Bernstein","year":"2011","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.autrev.2023.103486_bb0040","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.immuni.2015.10.023","article-title":"Immune interactions with pathogenic and commensal fungi: a two-way street","volume":"43","author":"Underhill","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2023.103486_bb0045","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.chom.2016.05.018","article-title":"The fungal mycobiota: small numbers, large impacts","volume":"19","author":"Kumamoto","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.autrev.2023.103486_bb0050","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/19490976.2020.1731287","article-title":"The mycobiota of the human body: a spark can start a prairie fire","volume":"11","author":"Zhang","year":"2020","journal-title":"Gut Microbes"},{"key":"10.1016\/j.autrev.2023.103486_bb0055","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/ibd\/izac156","article-title":"Mycobiome and inflammatory bowel disease: role in disease pathogenesis, current approaches and novel nutritional-based therapies","volume":"29","author":"Hsu","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2023.103486_bb0060","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3109\/1040841X.2013.813904","article-title":"Candida albicans, plasticity and pathogenesis","volume":"41","author":"Poulain","year":"2015","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.autrev.2023.103486_bb0065","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1007\/s10620-012-2244-y","article-title":"Anti-Saccharomyces cerevisiae antibodies associate with phenotypes and higher risk for surgery in Crohn\u2019s disease: a meta-analysis","volume":"57","author":"Zhang","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.autrev.2023.103486_bb0070","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/MEG.0000000000000102","article-title":"Serum antibodies to microbial antigens for Crohn\u2019s disease progression: a meta-analysis","volume":"26","author":"Xiong","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2023.103486_bb0075","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/gut.47.6.870a","article-title":"Mother to child transmission of anti-Saccharomyces cerevisiae mannan antibodies (ASCA) in non-IBD families","volume":"47","author":"Poulain","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2023.103486_bb0080","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/j.1572-0241.1998.00415.x","article-title":"Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn\u2019s disease","volume":"93","author":"Sendid","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2023.103486_bb0085","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0016-5085(98)70252-5","article-title":"Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease","volume":"115","author":"Ruemmele","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2023.103486_bb0090","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1572-0241.2001.03613.x","article-title":"Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease","volume":"96","author":"Peeters","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2023.103486_bb0095","article-title":"Machine learning in antibody diagnostics for inflammatory bowel disease subtype classification","volume":"13","author":"Sokollik","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.autrev.2023.103486_bb0100","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1053\/j.gastro.2006.04.030","article-title":"Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn\u2019s disease","volume":"131","author":"Dotan","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2023.103486_bb0105","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1053\/gast.2002.32980","article-title":"The value of serologic markers in indeterminate colitis: a prospective follow-up study","volume":"122","author":"Joossens","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2023.103486_bb0110","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1053\/j.gastro.2003.11.015","article-title":"Association of antibody responses to microbial antigens and complications of small bowel Crohn\u2019s disease","volume":"126","author":"Mow","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2023.103486_bb0115","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1136\/gut.2003.030734","article-title":"Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn\u2019s disease","volume":"53","author":"Forcione","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2023.103486_bb0120","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/gut.47.4.487","article-title":"Marker antibody expression stratifies Crohn\u2019s disease into immunologically homogeneous subgroups with distinct clinical characteristics","volume":"47","author":"Vasiliauskas","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2023.103486_bb0125","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/ibd.21179","article-title":"Serum anti-glycan antibodies predict complicated Crohn\u2019s disease behavior: a cohort study","volume":"16","author":"Rieder","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2023.103486_bb0130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/ibd.21046","article-title":"Association of the novel serologic anti-glycan antibodies anti-laminarin and anti-chitin with complicated Crohn\u2019s disease behavior","volume":"16","author":"Rieder","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2023.103486_bb0135","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1572-0241.2006.00468.x","article-title":"Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn\u2019s disease patients","volume":"101","author":"Amre","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2023.103486_bb0140","article-title":"Enterogenous microbiotic markers in the differential diagnosis of Crohn\u2019s disease and intestinal tuberculosis","volume":"13","author":"Jiang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103486_bb0145","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/ibd.22862","article-title":"Serum anti-glycan antibody biomarkers for inflammatory bowel disease diagnosis and progression: a systematic review and meta-analysis","volume":"18","author":"Kaul","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2023.103486_bb0150","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1080\/00365521.2020.1745879","article-title":"Serological antibodies and surgery in a population-based inception cohort of Crohn's disease patients - the IBSEN study","volume":"55","author":"Kristensen","year":"2020","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.autrev.2023.103486_bb0155","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1053\/j.gastro.2016.09.047","article-title":"Mechanisms, management, and treatment of fibrosis in patients with inflammatory bowel diseases","volume":"152","author":"Rieder","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2023.103486_bb0160","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/2050640616640160","article-title":"Biomarkers of intestinal fibrosis - one step towards clinical trials for structuring inflammatory bowel disease","volume":"4","author":"Giuffrida","year":"2016","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.autrev.2023.103486_bb0165","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/j.gastro.2020.07.065","article-title":"Pediatric inflammatory bowel disease-ahead steering, predicting outcomes in pediatric Crohn's disease for management optimization: systematic review and consensus statements from the pediatric inflammatory bowel disease-ahead program","volume":"160","author":"Ricciuto","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2023.103486_bb0170","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0022-3476(99)70202-7","article-title":"Serologic testing for inflammatory bowel disease","volume":"134","author":"Hoffenberg","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.autrev.2023.103486_bb0175","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000109928","article-title":"Diagnostic value of serological assays in pediatric inflammatory bowel disorders","volume":"75","author":"Mainardi","year":"2007","journal-title":"Digestion"},{"key":"10.1016\/j.autrev.2023.103486_bb0180","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/MPG.0000000000000239","article-title":"ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents","volume":"58","author":"Levine","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.autrev.2023.103486_bb0185","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/00365521.2016.1259653","article-title":"Serological markers in diagnosis of pediatric inflammatory bowel disease and as predictors for early tumor necrosis factor blocker therapy","volume":"52","author":"Olbjorn","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.autrev.2023.103486_bb0190","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/MPG.0000000000002311","article-title":"Anti-Saccharomyces cerevisiae antibodies as a prognostic biomarker in children with Crohn disease","volume":"69","author":"Chandrakumar","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.autrev.2023.103486_bb0195","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/003655201750065960","article-title":"Anti-Saccharomyces cerevisiae antibodies in inflammatory bowel disease: a family study","volume":"36","author":"Seibold","year":"2001","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.autrev.2023.103486_bb0200","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00054725-200102000-00002","article-title":"Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families","volume":"7","author":"Vermeire","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2023.103486_bb0205","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1136\/gut.2005.066860","article-title":"Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease","volume":"54","author":"Halfvarson","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2023.103486_bb0210","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/ibd.21903","article-title":"Serological antibodies in inflammatory bowel disease: a systematic review","volume":"18","author":"Prideaux","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2023.103486_bb0215","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1053\/gast.2002.35379","article-title":"Selected loss of tolerance evidenced by Crohn\u2019s disease-associated immune responses to auto- and microbial antigens","volume":"123","author":"Landers","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2023.103486_bb0220","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1136\/gut.2004.060228","article-title":"Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease","volume":"54","author":"Israeli","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2023.103486_bb0225","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2020.03.007","article-title":"Serum biomarkers identify patients who will develop inflammatory bowel diseases up to 5 years before diagnosis","volume":"159","author":"Torres","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2023.103486_bb0230","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/apt.17370","article-title":"Systematic review with meta-analysis: time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease","volume":"57","author":"Jayasooriya","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.autrev.2023.103486_bb0235","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1023\/A:1006968117252","article-title":"Characterization of oligosaccharides from an antigenic mannan of Saccharomyces cerevisiae","volume":"15","author":"Young","year":"1998","journal-title":"Glycoconj J"},{"key":"10.1016\/j.autrev.2023.103486_bb0240","doi-asserted-by":"crossref","first-page":"7669","DOI":"10.1016\/j.tet.2005.05.098","article-title":"Synthetic yeast oligomannosides as biological probes: \u03b1-D-man(1->3) \u03b1-D-man(1->2) \u03b1-D-man and \u03b1-D-man(1->3) \u03b1-D-man(1->2) \u03b1-D-man(1->2) \u03b1-D-man as Crohn\u2019s disease marker","volume":"61","author":"Chevalier","year":"2005","journal-title":"Tetrahedron"},{"key":"10.1016\/j.autrev.2023.103486_bb0245","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1572-0241.2007.01648.x","article-title":"Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn\u2019s disease patients and contributes to differential diagnosis, stratification, and prediction","volume":"103","author":"Vandewalle-El Khoury","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2023.103486_bb0250","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.bmc.2011.12.048","article-title":"Biotin sulfone tagged oligomannosides as immunogens for eliciting antibodies against specific mannan epitopes","volume":"20","author":"Despras","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.autrev.2023.103486_bb0255","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/gut.31.5.536","article-title":"Antibody to selected strains of Saccharomyces cerevisiae (baker\u2019s and brewer\u2019s yeast) and Candida albicans in Crohn\u2019s disease","volume":"31","author":"McKenzie","year":"1990","journal-title":"Gut"},{"issue":"Pt 10","key":"10.1016\/j.autrev.2023.103486_bb0260","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1099\/13500872-141-10-2693","article-title":"Mapping of beta-1,2-linked oligomannosidic epitopes among glycoconjugates of Candida species","volume":"141","author":"Cantelli","year":"1995","journal-title":"Microbiology (Reading)"},{"key":"10.1016\/j.autrev.2023.103486_bb0265","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1128\/IAI.00368-08","article-title":"Beta-1,2 oligomannose adhesin epitopes are widely distributed over the different families of Candida albicans cell wall mannoproteins and are associated through both N- and O-glycosylation processes","volume":"76","author":"Fradin","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.autrev.2023.103486_bb0270","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1128\/iai.60.9.3845-3851.1992","article-title":"Mapping of Candida albicans oligomannosidic epitopes by using monoclonal antibodies","volume":"60","author":"Trinel","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.autrev.2023.103486_bb0275","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0165-2478(98)00003-0","article-title":"Humoral immune response to a 200-kDa glycoprotein antigen of Saccharomyces cerevisiae is common in man","volume":"61","author":"Sander","year":"1998","journal-title":"Immunol Lett"},{"key":"10.1016\/j.autrev.2023.103486_bb0280","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1574-6968.1994.tb06844.x","article-title":"A murine monoclonal antibody directed against a yeast cell wall glycoprotein antigen of the yeast genus Saccharomyces","volume":"118","author":"Broker","year":"1994","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.autrev.2023.103486_bb0285","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1159\/000320396","article-title":"New serologic markers for inflammatory bowel disease diagnosis","volume":"28","author":"Dotan","year":"2010","journal-title":"Dig Dis"},{"key":"10.1016\/j.autrev.2023.103486_bb0290","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1080\/00365520601083625","article-title":"Ethnic and socio-cultural specificities in Tunisia have no impact on the prevalence of anti-Saccharomyces cerevisiae antibodies in Crohn\u2019s disease patients, their relatives or associated clinical factors","volume":"42","author":"Hadrich","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.autrev.2023.103486_bb0295","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1053\/gast.2001.22546","article-title":"Comparative study of ASCA (anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease","volume":"120","author":"Vermeire","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2023.103486_bb0300","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1365-2036.2004.02258.x","article-title":"Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features","volume":"20","author":"Annese","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.autrev.2023.103486_bb0305","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/ecco-jcc\/jjaa220","article-title":"The impact of NOD2 genetic variants on the gut mycobiota in Crohn\u2019s disease patients in remission and in individuals without gastrointestinal inflammation","volume":"15","author":"Nelson","year":"2021","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.autrev.2023.103486_bb0310","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1053\/j.gastro.2006.02.009","article-title":"Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn\u2019s disease","volume":"130","author":"Standaert-Vitse","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2023.103486_bb0315","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1086\/528990","article-title":"Colonization of mice by Candida albicans is promoted by chemically induced colitis and augments inflammatory responses through galectin-3","volume":"197","author":"Jawhara","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2023.103486_bb0320","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1128\/CVI.00200-08","article-title":"Antibodies against glucan, chitin, and Saccharomyces cerevisiae mannan as new biomarkers of Candida albicans infection that complement tests based on C. albicans mannan","volume":"15","author":"Sendid","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2023.103486_bb0325","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000268129","article-title":"Yeasts: neglected pathogens","volume":"27","author":"Poulain","year":"2009","journal-title":"Dig Dis"},{"key":"10.1016\/j.autrev.2023.103486_bb0330","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1136\/gut.2010.208348","article-title":"Mannan-binding lectin deficiency results in unusual antibody production and excessive experimental colitis in response to mannose-expressing mild gut pathogens","volume":"59","author":"Muller","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2023.103486_bb0335","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/ibd.20228","article-title":"Anti-Saccharomyces cerevisiae mannan antibodies (ASCA) of Crohn\u2019s patients crossreact with mannan from other yeast strains, and murine ASCA IgM can be experimentally induced with Candida albicans","volume":"13","author":"Schaffer","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2023.103486_bb0340","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0304-4165(98)00132-9","article-title":"Asparagine-linked glycosylation in the yeast Golgi","volume":"1426","author":"Dean","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.autrev.2023.103486_bb0345","first-page":"2438","article-title":"Protein O-mannosylation: what we have learned from baker\u2019s yeast","volume":"2013","author":"Loibl","year":"1833","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.autrev.2023.103486_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.4.1.1","article-title":"Candida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanisms of action","volume":"4","author":"Nelson","year":"1991","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.autrev.2023.103486_bb0355","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2183\/pjab.88.250","article-title":"Immunochemistry of pathogenic yeast, Candida species, focusing on mannan","volume":"88","author":"Shibata","year":"2012","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"10.1016\/j.autrev.2023.103486_bb0360","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1038\/s41564-021-00983-z","article-title":"Mycobiota-induced IgA antibodies regulate fungal commensalism in the gut and are dysregulated in Crohn's disease","volume":"6","author":"Doron","year":"2021","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.autrev.2023.103486_bb0365","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41586-021-03722-w","article-title":"Adaptive immunity induces mutualism between commensal eukaryotes","volume":"596","author":"Ost","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2023.103486_bb0370","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/0006-291X(91)91664-X","article-title":"Candida albicans serotype A strains grow in yeast extract-added Sabouraud liquid medium at pH 2.0, elaborating mannans without beta-1,2 linkage and phosphate group","volume":"175","author":"Kobayashi","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2023.103486_bb0375","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0014-5793(94)00434-X","article-title":"Temperature-dependent change of serological specificity of Candida albicans NIH A-207 cells cultured in yeast extract-added Sabouraud liquid medium: disappearance of surface antigenic factors 4, 5, and 6 at high temperature","volume":"345","author":"Okawa","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1016\/j.autrev.2023.103486_bb0380","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1042\/BJ20070081","article-title":"Chemical structure of the cell-wall mannan of Candida albicans serotype A and its difference in yeast and hyphal forms","volume":"404","author":"Shibata","year":"2007","journal-title":"Biochem J"},{"key":"10.1016\/j.autrev.2023.103486_bb0385","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200275RRR","article-title":"The mitochondrial complex I proteins of Candida albicans moderate phagocytosis and the production of pro-inflammatory cytokines in murine macrophages and dendritic cells","volume":"36","author":"She","year":"2022","journal-title":"FASEB J"},{"issue":"6","key":"10.1016\/j.autrev.2023.103486_bb0390","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3390\/jof9060636","article-title":"Antibodies as models and tools to decipher Candida albicans pathogenic development: review about a unique monoclonal antibody reacting with immunomodulatory adhesins","volume":"9","author":"Leroy","year":"2023","journal-title":"J Fungi (Basel)"},{"issue":"2","key":"10.1016\/j.autrev.2023.103486_bb0395","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41575-021-00541-2","article-title":"Mycobiota-host immune interactions in IBD: coming out of the shadows","volume":"19","author":"Iliev","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2023.103486_bb0400","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood.V96.6.2055","article-title":"Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial","volume":"96","author":"Marr","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2023.103486_bb0405","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.3748\/wjg.v26.i28.3998","article-title":"Secondary causes of inflammatory bowel diseases","volume":"26","author":"Ghouri","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.autrev.2023.103486_bb0410","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3390\/jof7050324","article-title":"A pilot clinical study on post-operative recurrence provides biological clues for a role of Candida yeasts and fluconazole in Crohn\u2019s disease","volume":"7","author":"Sendid","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.autrev.2023.103486_bb0415","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.coi.2010.06.009","article-title":"Inborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines?","volume":"22","author":"Puel","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2023.103486_bb0420","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1056\/NEJMoa0810719","article-title":"A homozygous CARD9 mutation in a family with susceptibility to fungal infections","volume":"361","author":"Glocker","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2023.103486_bb0425","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2016.71","article-title":"Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity","volume":"5","author":"Okada","year":"2016","journal-title":"Clin Transl Immunology"},{"key":"10.1016\/j.autrev.2023.103486_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2021.01.016","article-title":"Human gut mycobiota tune immunity via CARD9-dependent induction of anti-fungal IgG antibodies","volume":"184","author":"Doron","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2023.103486_bb0435","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nm.4102","article-title":"CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands","volume":"22","author":"Lamas","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2023.103486_bb0440","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1462-5822.2009.01318.x","article-title":"Host responses to a versatile commensal: PAMPs and PRRs interplay leading to tolerance or infection by Candida albicans","volume":"11","author":"Jouault","year":"2009","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.autrev.2023.103486_bb0445","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.tim.2014.07.001","article-title":"Metabolism impacts upon Candida immunogenicity and pathogenicity at multiple levels","volume":"22","author":"Brown","year":"2014","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.autrev.2023.103486_bb0450","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrmicro1815","article-title":"An integrated model of the recognition of Candida albicans by the innate immune system","volume":"6","author":"Netea","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.autrev.2023.103486_bb0455","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nri3897","article-title":"Immune defence against Candida fungal infections","volume":"15","author":"Netea","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2023.103486_bb0460","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1126\/science.aao1503","article-title":"CX3CR1(+) mononuclear phagocytes control immunity to intestinal fungi","volume":"359","author":"Leonardi","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.autrev.2023.103486_bb0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41586-021-04178-8","article-title":"Immune regulation by fungal strain diversity in inflammatory bowel disease","author":"Li","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2023.103486_bb0470","doi-asserted-by":"crossref","first-page":"S290","DOI":"10.1016\/S1873-9946(13)60718-7","article-title":"Candida albicans colonization and anti-glycan antibodies in active and quiescent Crohn\u2019s disease","volume":"7","author":"Gerard","year":"2013","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.autrev.2023.103486_bb0475","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.cca.2010.12.029","article-title":"Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, are new markers in Crohn\u2019s disease","volume":"412","author":"Roggenbuck","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.autrev.2023.103486_bb0480","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.autrev.2014.11.004","article-title":"Systematic review: new serological markers (anti-glycan, anti-GP2, anti-GM-CSF Ab) in the prediction of IBD patient outcomes","volume":"14","author":"Bonneau","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2023.103486_bb0485","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/MOG.0000000000000076","article-title":"Serological studies in inflammatory bowel disease: how important are they?","volume":"30","author":"Papp","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.autrev.2023.103486_bb0490","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2018.1","article-title":"Antibodies against glycoprotein 2 display diagnostic advantages over ASCA in distinguishing CD from intestinal tuberculosis and intestinal Behcet's disease","volume":"9","author":"Zhang","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.autrev.2023.103486_bb0495","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s41467-021-21277-2","article-title":"Pancreatic glycoprotein 2 is a first line of defense for mucosal protection in intestinal inflammation","volume":"12","author":"Kurashima","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2023.103486_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109214","article-title":"Human glycoprotein-2 expressed in Brunner glands \u2013 a putative autoimmune target and link between Crohn\u2019s and coeliac disease","volume":"247","author":"Roggenbuck","year":"2023","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2023.103486_bb0505","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1053\/j.gastro.2004.04.061","article-title":"High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn\u2019s disease","volume":"127","author":"Darfeuille-Michaud","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2023.103486_bb0510","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4161\/viru.1.4.11510","article-title":"Abnormal CEACAM6 expression in Crohn disease patients favors gut colonization and inflammation by adherent-invasive E. coli","volume":"1","author":"Barnich","year":"2010","journal-title":"Virulence"},{"key":"10.1016\/j.autrev.2023.103486_bb0515","doi-asserted-by":"crossref","first-page":"742","DOI":"10.3389\/fmicb.2018.00742","article-title":"Oligomannose-rich membranes of dying intestinal epithelial cells promote host colonization by adherent-invasive E. coli","volume":"9","author":"Dumych","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.autrev.2023.103486_bb0520","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4161\/gmic.1.6.14078","article-title":"Glycoprotein 2 (GP2): grabbing the FimH bacteria into M cells for mucosal immunity","volume":"1","author":"Ohno","year":"2010","journal-title":"Gut Microbes"},{"key":"10.1016\/j.autrev.2023.103486_bb0525","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nm.1874","article-title":"Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis","volume":"14","author":"Kain","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2023.103486_bb0530","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/eji.200535149","article-title":"Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection","volume":"36","author":"Fischer","year":"2006","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2023.103486_bb0535","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/cncr.27794","article-title":"CD66c is a novel marker for colorectal cancer stem cell isolation, and its silencing halts tumor growth in vivo","volume":"119","author":"Gemei","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.autrev.2023.103486_bb0540","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1172\/JCI30504","article-title":"CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease","volume":"117","author":"Barnich","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2023.103486_bb0545","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s40168-021-01135-5","article-title":"Blockage of bacterial FimH prevents mucosal inflammation associated with Crohn's disease","volume":"9","author":"Chevalier","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.autrev.2023.103486_bb0550","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/MIB.0000000000000280","article-title":"Saccharomyces cerevisiae CNCM I-3856 prevents colitis induced by AIEC bacteria in the transgenic mouse model mimicking Crohn\u2019s disease","volume":"21","author":"Sivignon","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2023.103486_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118415","article-title":"Heteropolysaccharides from S. cerevisiae show anti-adhesive properties against E. coli associated with Crohn's disease","volume":"271","author":"Sivignon","year":"2021","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.autrev.2023.103486_bb0560","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23112794","article-title":"A novel integrated way for deciphering the glycan code for the FimH lectin","volume":"23","author":"Dumych","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.autrev.2023.103486_bb0565","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02142-16","article-title":"Binding of Candida albicans to human CEACAM1 and CEACAM6 modulates the inflammatory response of intestinal epithelial cells","volume":"8","author":"Klaile","year":"2017","journal-title":"MBio"},{"key":"10.1016\/j.autrev.2023.103486_bb0570","article-title":"Antibody ligation of CEACAM1, CEACAM3, and CEACAM6, differentially enhance the cytokine release of human neutrophils in responses to Candida albicans","volume":"371","author":"Klaile","year":"2021","journal-title":"Cell Immunol"},{"key":"10.1016\/j.autrev.2023.103486_bb0575","article-title":"Constructing a human complex type N-linked glycosylation pathway in Kluyveromyces marxianus","volume":"15","author":"Lee","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2023.103486_bb0580","doi-asserted-by":"crossref","first-page":"8789","DOI":"10.1074\/jbc.M114.631622","article-title":"Human neutrophils secrete bioactive paucimannosidic proteins from azurophilic granules into pathogen-infected sputum","volume":"290","author":"Thaysen-Andersen","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2023.103486_bb0585","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1107\/S2059798322007082","article-title":"Native glycosylation and binding of the antidepressant paroxetine in a low-resolution crystal structure of human myeloperoxidase","volume":"78","author":"Krawczyk","year":"2022","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"10.1016\/j.autrev.2023.103486_bb0590","doi-asserted-by":"crossref","first-page":"20233","DOI":"10.1074\/jbc.RA119.011098","article-title":"Neutrophil myeloperoxidase harbors distinct site-specific peculiarities in its glycosylation","volume":"294","author":"Reiding","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2023.103486_bb0595","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/glycob\/cwab027","article-title":"Minimal epitope for Mannitou IgM on paucimannose-carrying glycoproteins","volume":"31","author":"Robakiewicz","year":"2021","journal-title":"Glycobiology"},{"key":"10.1016\/j.autrev.2023.103486_bb0600","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.R120.002093","article-title":"Meta-heterogeneity: evaluating and describing the diversity in glycosylation between sites on the same glycoprotein","volume":"20","author":"\u010caval","year":"2021","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.autrev.2023.103486_bb0605","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/ibd\/izac244","article-title":"Human fecal mucin glycosylation as a new biomarker in inflammatory bowel diseases","volume":"29","author":"Robbe Masselot","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2023.103486_bb0610","doi-asserted-by":"crossref","first-page":"1006939","DOI":"10.3389\/fimmu.2022.1006939","article-title":"IgG subclass and Fc glycosylation shifts are linked to the transition from pre- to inflammatory autoimmune conditions","volume":"13","author":"Buhre","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103486_bb0615","article-title":"Alterations of golgi structural proteins and glycosylation defects in cancer","volume":"9","author":"Zhang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.autrev.2023.103486_bb0620","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41385-021-00466-8","article-title":"Finding the sweet spot: glycosylation mediated regulation of intestinal inflammation","volume":"15","author":"Brazil","year":"2022","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.autrev.2023.103486_bb0625","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01250-16","article-title":"Bacteriome and mycobiome interactions underscore microbial dysbiosis in familial Crohn's disease","volume":"7","author":"Hoarau","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.autrev.2023.103486_bb0630","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1136\/gutjnl-2015-310746","article-title":"Fungal microbiota dysbiosis in IBD","volume":"66","author":"Sokol","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2023.103486_bb0635","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.immuni.2019.05.023","article-title":"Gut mycobiota in immunity and inflammatory disease","volume":"50","author":"Li","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2023.103486_bb0640","doi-asserted-by":"crossref","first-page":"2168992","DOI":"10.1080\/19490976.2023.2168992","article-title":"Fungal feelings in the irritable bowel syndrome: the intestinal mycobiome and abdominal pain","volume":"15","author":"van Thiel","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.autrev.2023.103486_bb0645","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/yea.1601","article-title":"Relatedness of medically important strains of Saccharomyces cerevisiae as revealed by phylogenetics and metabolomics","volume":"25","author":"MacKenzie","year":"2008","journal-title":"Yeast"},{"key":"10.1016\/j.autrev.2023.103486_bb0650","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040648","article-title":"Modulation of intestinal inflammation by yeasts and cell wall extracts: strain dependence and unexpected anti-inflammatory role of glucan fractions","volume":"7","author":"Jawhara","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2023.103486_bb0655","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/13693780701523013","article-title":"Saccharomyces boulardii decreases inflammation and intestinal colonization by Candida albicans in a mouse model of chemically-induced colitis","volume":"45","author":"Jawhara","year":"2007","journal-title":"Med Mycol"},{"key":"10.1016\/j.autrev.2023.103486_bb0660","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrgastro.2014.188","article-title":"Mycobiota in gastrointestinal diseases","volume":"12","author":"Mukherjee","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2023.103486_bb0665","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/ajg.2009.225","article-title":"Candida albicans colonization and ASCA in familial Crohn\u2019s disease","volume":"104","author":"Standaert-Vitse","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2023.103486_bb0670","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/ecco-jcc\/jjv209","article-title":"Fungal dysbiosis in mucosa-associated microbiota of Crohn\u2019s disease patients","volume":"10","author":"Liguori","year":"2016","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.autrev.2023.103486_bb0675","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13099-018-0277-2","article-title":"A decrease in anaerobic bacteria promotes Candida glabrata overgrowth while beta-glucan treatment restores the gut microbiota and attenuates colitis","volume":"10","author":"Charlet","year":"2018","journal-title":"Gut Pathog"},{"key":"10.1016\/j.autrev.2023.103486_bb0680","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1038\/s41598-018-21422-w","article-title":"Remodeling of the Candida glabrata cell wall in the gastrointestinal tract affects the gut microbiota and the immune response","volume":"8","author":"Charlet","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2023.103486_bb0685","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1126\/science.abd0919","article-title":"Debaryomyces is enriched in Crohn's disease intestinal tissue and impairs healing in mice","volume":"371","author":"Jain","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.autrev.2023.103486_bb0690","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.csbj.2022.01.008","article-title":"Analyzing the human gut mycobiome \u2013 a short guide for beginners","volume":"20","author":"Thielemann","year":"2022","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.autrev.2023.103486_bb0695","article-title":"The ileal fungal microbiota is altered in Crohn's disease and is associated with the disease course","volume":"9","author":"Olaisen","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.autrev.2023.103486_bb0700","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.chom.2019.01.007","article-title":"Malassezia is associated with Crohn\u2019s disease and exacerbates colitis in mouse models","volume":"25","author":"Limon","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.autrev.2023.103486_bb0705","first-page":"77","article-title":"The genus Malassezia: old facts and new concepts","volume":"50","author":"Guillot","year":"2008","journal-title":"Parassitologia"},{"key":"10.1016\/j.autrev.2023.103486_bb0710","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1146\/annurev-micro-040820-010114","article-title":"Malassezia: a commensal, pathogen, and mutualist of human and animal skin","volume":"76","author":"Ianiri","year":"2022","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.autrev.2023.103486_bb0715","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1093\/mmy\/myx134","article-title":"Malassezia ecology, pathophysiology, and treatment","volume":"56","author":"Theelen","year":"2018","journal-title":"Med Mycol"},{"key":"10.1016\/j.autrev.2023.103486_bb0720","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1439-0507.2009.01814.x","article-title":"Minireview: Malassezia infections in immunocompromised patients","volume":"53","author":"Tragiannidis","year":"2010","journal-title":"Mycoses"},{"key":"10.1016\/j.autrev.2023.103486_bb0725","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3390\/jof7100855","article-title":"Chronic diseases associated with Malassezia yeast","volume":"7","author":"Abdillah","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.autrev.2023.103486_bb0730","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3389\/fcimb.2020.00370","article-title":"Malassezia spp. yeasts of emerging concern in fungemia","volume":"10","author":"Rhimi","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.autrev.2023.103486_bb0735","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3390\/jof7100824","article-title":"MalaSelect: a selective culture medium for Malassezia species","volume":"7","author":"Abdillah","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.autrev.2023.103486_bb0740","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.3748\/wjg.v29.i14.2172","article-title":"Changes in the gut mycobiome in pediatric patients in relation to the clinical activity of Crohn's disease","volume":"29","author":"Krawczyk","year":"2023","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.autrev.2023.103486_bb0745","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.3389\/fmicb.2018.02208","article-title":"Characterizing the human mycobiota: a comparison of small subunit rRNA, ITS1, ITS2, and large subunit rRNA genomic targets","volume":"9","author":"Hoggard","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.autrev.2023.103486_bb0750","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s40168-017-0373-4","article-title":"The gut mycobiome of the human microbiome project healthy cohort","volume":"5","author":"Nash","year":"2017","journal-title":"Microbiome"},{"key":"10.1016\/j.autrev.2023.103486_bb0755","doi-asserted-by":"crossref","first-page":"16788","DOI":"10.1038\/s41598-017-17132-4","article-title":"Culturomics and amplicon-based metagenomic approaches for the study of fungal population in human gut microbiota","volume":"7","author":"Hamad","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2023.103486_bb0760","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.777133","article-title":"The isolation and characterization of rare mycobiome associated with spacecraft assembly cleanrooms","volume":"13","author":"Blachowicz","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.autrev.2023.103486_bb0765","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090899","article-title":"Redefining the human oral mycobiome with improved practices in amplicon-based taxonomy: discovery of Malassezia as a prominent commensal","volume":"9","author":"Dupuy","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2023.103486_bb0770","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2222.1992.tb00149.x","article-title":"Crossreacting IgE antibodies to Pityrosporum ovale and Candida albicans in atopic children","volume":"22","author":"Savolainen","year":"1992","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.autrev.2023.103486_bb0775","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1023\/A:1011994120527","article-title":"IgG and IgE immune response against the surface glycoprotein gp200 of Saccharomyces cerevisiae in patients with atopic dermatitis","volume":"152","author":"Nenoff","year":"2001","journal-title":"Mycopathologia"},{"key":"10.1016\/j.autrev.2023.103486_bb0780","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1007\/s10620-010-1523-8","article-title":"Serum antibodies to Mycobacterium avium subspecies paratuberculosis combined with anti-Saccharomyces cerevisiae antibodies in Crohn\u2019s disease patients: prevalence and diagnostic role","volume":"56","author":"Biet","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.autrev.2023.103486_bb0785","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1053\/j.gastro.2007.08.004","article-title":"Microbial mannan inhibits bacterial killing by macrophages: a possible pathogenic mechanism for Crohn\u2019s disease","volume":"133","author":"Mpofu","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2023.103486_bb0790","first-page":"1","article-title":"Detection of a novel antigen for Crohn\u2019s disease","author":"Wei","year":"2021","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.autrev.2023.103486_bb0795","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nature11582","article-title":"Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease","volume":"491","author":"Jostins","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2023.103486_bb0800","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104113","article-title":"The gut virome: a new microbiome component in health and disease","volume":"81","author":"Cao","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.autrev.2023.103486_bb0805","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1177\/2050640619876787","article-title":"The gut virome in inflammatory bowel disease pathogenesis: from metagenomics to novel therapeutic approaches","volume":"7","author":"Ungaro","year":"2019","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.autrev.2023.103486_bb0810","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1016\/j.cell.2022.07.003","article-title":"Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation","volume":"185","author":"Federici","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2023.103486_bb0815","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.3390\/microorganisms8091420","article-title":"Phage therapy in gastrointestinal diseases","volume":"8","author":"Gutierrez","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.autrev.2023.103486_bb0820","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/v15010173","article-title":"The emerging role of the gut virome in health and inflammatory bowel disease: challenges, covariates and a viral imbalance","volume":"15","author":"Jansen","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.autrev.2023.103486_bb0825","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s12551-020-00698-1","article-title":"Biophysical characterization of dynamic structures of immunoglobulin G","volume":"12","author":"Yanaka","year":"2020","journal-title":"Biophys Rev"},{"key":"10.1016\/j.autrev.2023.103486_bb0830","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1749-6632.2009.04673.x","article-title":"Infectious serologies and autoantibodies in inflammatory bowel disease: insinuations at a true pathogenic role","volume":"1173","author":"Lidar","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2023.103486_bb0835","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1097\/MIB.0000000000001167","article-title":"Looking into enteric virome in patients with IBD: defining guilty or innocence\u202f?","volume":"23","author":"Lopes","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2023.103486_bb0840","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2217\/fvl.15.80","article-title":"EBV glycoproteins: where are we now?","volume":"10","author":"Hutt-Fletcher","year":"2015","journal-title":"Future Virol"},{"key":"10.1016\/j.autrev.2023.103486_bb0845","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1128\/CVI.00527-09","article-title":"Mannose-binding lectin genotypes and susceptibility to epstein-barr virus infection in infancy","volume":"17","author":"Friborg","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.autrev.2023.103486_bb0850","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.crohns.2012.03.008","article-title":"Low mannose-binding lectin (MBL) is associated with paediatric inflammatory bowel diseases and ileal involvement in patients with Crohn disease","volume":"7","author":"Kovacs","year":"2013","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.autrev.2023.103486_bb0855","doi-asserted-by":"crossref","first-page":"29636","DOI":"10.1038\/srep29636","article-title":"Polymorphisms in the mannose-binding lectin gene are associated with defective mannose-binding lectin functional activity in Crohn\u2019s disease patients","volume":"6","author":"Choteau","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2023.103486_bb0860","doi-asserted-by":"crossref","first-page":"11612","DOI":"10.1073\/pnas.1514484112","article-title":"Evasion of affinity-based selection in germinal centers by Epstein-Barr virus LMP2A","volume":"112","author":"Minamitani","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2023.103486_bb0865","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121776","article-title":"Humoral immunity links Candida albicans infection and celiac disease","volume":"10","author":"Corouge","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2023.103486_bb0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102621","article-title":"Candida albicans in celiac disease: a wolf in sheep\u2019s clothing","volume":"19","author":"Aaron","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2023.103486_bb0875","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/MCG.0000000000000089","article-title":"Early microbial markers of celiac disease","volume":"48","author":"Viitasalo","year":"2014","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.autrev.2023.103486_bb0880","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/hep.30832","article-title":"Intestinal fungal dysbiosis and systemic immune response to fungi in patients with alcoholic hepatitis","volume":"71","author":"Lang","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2023.103486_bb0885","first-page":"2289","article-title":"Serology of patients with ulcerative colitis after pouch surgery is more comparable with that of patients with Crohn\u2019s disease","volume":"21","author":"Goren","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2023.103486_bb0890","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.chom.2020.03.006","article-title":"Fungal trans-kingdom dynamics linked to responsiveness to fecal microbiota transplantation (FMT) therapy in ulcerative colitis","volume":"27","author":"Leonardi","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.autrev.2023.103486_bb0895","doi-asserted-by":"crossref","first-page":"1086885","DOI":"10.3389\/fcimb.2022.1086885","article-title":"Specific fungi associated with response to capsulized fecal microbiota transplantation in patients with active ulcerative colitis","volume":"12","author":"Chen","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.autrev.2023.103486_bb0900","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/MCG.0000000000001609","article-title":"Oral fluconazole therapy in patients with active ulcerative colitis who have detectable Candida in the stool\u202f: a double-blind randomized placebo-controlled trial","volume":"56","author":"Jena","year":"2022","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.autrev.2023.103486_bb0905","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/ibd\/izy370","article-title":"Starch consumption may modify antiglycan antibodies and fecal fungal composition in patients with ileo-anal pouch","volume":"25","author":"Goren","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2023.103486_bb0910","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1053\/j.gastro.2020.10.066","article-title":"The microbiota-gut-brain axis: from motility to mood","volume":"160","author":"Margolis","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2023.103486_bb0915","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.chom.2021.08.004","article-title":"Aberrant gut-microbiota-immune-brain axis development in premature neonates with brain damage","volume":"29","author":"Seki","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.autrev.2023.103486_bb0920","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3389\/fneur.2017.00535","article-title":"The role of fungi in the etiology of multiple sclerosis","volume":"8","author":"Benito-Leon","year":"2017","journal-title":"Front Neurol"},{"key":"10.1016\/j.autrev.2023.103486_bb0925","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1016\/j.cell.2022.09.005","article-title":"Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions","volume":"185","author":"Narunsky-Haziza","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2023.103486_bb0930","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1016\/j.cell.2022.09.015","article-title":"A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors","volume":"185","author":"Dohlman","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2023.103486_bb0935","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020105320","article-title":"Fungal-induced glycolysis in macrophages promotes colon cancer by enhancing innate lymphoid cell secretion of IL-22","volume":"40","author":"Zhu","year":"2021","journal-title":"EMBO J"},{"key":"10.1016\/j.autrev.2023.103486_bb0940","doi-asserted-by":"crossref","DOI":"10.1016\/j.mycmed.2023.101378","article-title":"Candida albicans and human health: a new concept in terms of the microbiota revolution ?","volume":"33","author":"Poulain","year":"2023","journal-title":"J Mycol Med"},{"key":"10.1016\/j.autrev.2023.103486_bb0945","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1038\/s41591-023-02556-5","article-title":"Selection of cross-reactive T cells by commensal and food-derived yeasts drives cytotoxic T(H)1 cell responses in Crohn's disease","volume":"29","author":"Martini","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2023.103486_bb0950","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1038\/s41590-023-01637-4","article-title":"Fungal microbiota sustains lasting immune activation of neutrophils and their progenitors in severe COVID-19","volume":"24","author":"Kusakabe","year":"2023","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2023.103486_bb0955","doi-asserted-by":"crossref","DOI":"10.1172\/JCI155786","article-title":"Fungal microbiome in inflammatory bowel disease: a critical assessment","volume":"132","author":"Underhill","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2023.103486_bb0960","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1365-2249.2003.02392.x","article-title":"Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn\u2019s disease are associated with disease severity but not NOD2\/CARD15 mutations","volume":"135","author":"Walker","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2023.103486_bb0965","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.cgh.2011.09.016","article-title":"Antimicrobial antibodies are associated with a Crohn's disease-like phenotype after ileal pouch-anal anastomosis","volume":"10","author":"Tyler","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2023.103486_bb0970","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1590\/S0004-28032010000300006","article-title":"Antibodies anti-Saccharomyces cerevisiae (ASCA) do not differentiate Crohn\u2019s disease from celiac disease","volume":"47","author":"Kotze","year":"2010","journal-title":"Arq Gastroenterol"},{"key":"10.1016\/j.autrev.2023.103486_bb0975","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s10620-021-06823-8","article-title":"Fungal dysbiosis in children with celiac disease","volume":"67","author":"El Mouzan","year":"2022","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.autrev.2023.103486_bb0980","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/ajg.2016.227","article-title":"No change in the mucosal gut mycobioma is associated with celiac disease-specific microbiome alteration in adult patients","volume":"111","author":"D\u2019Argenio","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2023.103486_bb0985","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13099-017-0173-1","article-title":"Significantly higher faecal counts of the yeasts Candida and Saccharomyces identified in people with coeliac disease","volume":"9","author":"Harnett","year":"2017","journal-title":"Gut Pathog"},{"key":"10.1016\/j.autrev.2023.103486_bb0990","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41591-019-0709-7","article-title":"High-resolution mycobiota analysis reveals dynamic intestinal translocation preceding invasive candidiasis","volume":"26","author":"Zhai","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2023.103486_bb0995","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/jof6040225","article-title":"Perinuclear anti-neutrophil cytoplasmic antibodies (pANCA) impair neutrophil candidacidal activity and are increased in the cellular fraction of vaginal samples from women with vulvovaginal candidiasis","volume":"6","author":"Ardizzoni","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.autrev.2023.103486_bb1000","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nri.2017.55","article-title":"Fungal dysbiosis: immunity and interactions at mucosal barriers","volume":"17","author":"Iliev","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2023.103486_bb1005","first-page":"100625","article-title":"Gut mycobiome in metabolic diseases: mechanisms and clinical implication","author":"Zhou","year":"2023","journal-title":"Biom J"},{"key":"10.1016\/j.autrev.2023.103486_bb1010","first-page":"37","article-title":"Anti-Saccharomyces cerevisiae as unusual antibodies in autoimmune hepatitis","volume":"55","author":"Fagoonee","year":"2009","journal-title":"Minerva Gastroenterol Dietol"},{"key":"10.1016\/j.autrev.2023.103486_bb1015","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/gutjnl-2018-317791","article-title":"Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis","volume":"69","author":"Lemoinne","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2023.103486_bb1020","article-title":"Candida spp. in human intestinal health and disease: more than a gut feeling","volume":"9","author":"Kreulen","year":"2023","journal-title":"Mycopathologia"},{"key":"10.1016\/j.autrev.2023.103486_bb1025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012957","article-title":"Presence of anti-microbial antibodies in liver cirrhosis--a tell-tale sign of compromised immunity?","volume":"5","author":"Papp","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2023.103486_bb1030","article-title":"Gut dysbiosis as a driver in alcohol-induced liver injury","volume":"3","author":"Fairfield","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.autrev.2023.103486_bb1035","article-title":"The role of the cutaneous mycobiome in atopic dermatitis","volume":"8","author":"Szczepanska","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.autrev.2023.103486_bb1040","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jaci.2020.01.045","article-title":"Anti-Saccharomyces cerevisiae IgG and IgA antibodies are associated with systemic inflammation and advanced disease in hidradenitis suppurativa","volume":"146","author":"Assan","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2023.103486_bb1045","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1159\/000530434","article-title":"Chronic inflammatory intestinal disorders in hidradenitis suppurativa","volume":"239","author":"Reka","year":"2023","journal-title":"Dermatology"},{"key":"10.1016\/j.autrev.2023.103486_bb1050","doi-asserted-by":"crossref","first-page":"e580","DOI":"10.1111\/jdv.18075","article-title":"Amplicon sequencing demonstrates comparable follicular mycobiomes in patients with hidradenitis suppurativa compared with healthy controls","volume":"36","author":"Ring","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.autrev.2023.103486_bb1055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/01.mpg.0000166801.61708.60","article-title":"Frequency of ASCA seropositivity in children with cystic fibrosis","volume":"41","author":"Condino","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.autrev.2023.103486_bb1060","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1183\/09031936.00006009","article-title":"Prevalence and clinical significance of auto-antibodies in adults with cystic fibrosis","volume":"34","author":"Lachenal","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.autrev.2023.103486_bb1065","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1186\/2047-783X-16-9-385","article-title":"Increased levels of anti-glycan antibodies in patients with cystic fibrosis","volume":"16","author":"Hirche","year":"2011","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.autrev.2023.103486_bb1070","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3390\/genes11050536","article-title":"The microbiome in cystic fibrosis pulmonary disease","volume":"11","author":"Francoise","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.autrev.2023.103486_bb1075","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1038\/s41598-020-60015-4","article-title":"Mucofong investigation, respiratory mycobiome and suggestion of inter-kingdom network during acute pulmonary exacerbation in cystic fibrosis","volume":"10","author":"Soret","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2023.103486_bb1080","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.890298","article-title":"Proinflammatory mucosal-associated invariant CD8+ T cells react to gut flora yeasts and infiltrate multiple sclerosis brain","volume":"13","author":"Gargano","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103486_bb1085","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/ene.12072","article-title":"Antibody response against gastrointestinal antigens in demyelinating diseases of the central nervous system","volume":"20","author":"Banati","year":"2013","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.autrev.2023.103486_bb1090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103557","article-title":"Alterations of the gut mycobiome in patients with MS","volume":"71","author":"Shah","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.autrev.2023.103486_bb1095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264556","article-title":"Multiple sclerosis patients have an altered gut mycobiome and increased fungal to bacterial richness","volume":"17","author":"Yadav","year":"2022","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2023.103486_bb1100","first-page":"S87","article-title":"Anti-Saccharomyces cerevisiae antibodies in Behcet\u2019s disease--a familial study","volume":"24","author":"Monselise","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2023.103486_bb1105","first-page":"S21","article-title":"Anti-Saccharomyces cerevisiae antibodies--a novel serologic marker for Behcet's disease","volume":"20","author":"Krause","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2023.103486_bb1110","first-page":"S67","article-title":"Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behcet\u2019s syndrome","volume":"23","author":"Fresko","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2023.103486_bb1115","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3346\/jkms.2005.20.6.971","article-title":"Comparison of Behcet\u2019s disease and recurrent aphthous ulcer according to characteristics of gastrointestinal symptoms","volume":"20","author":"Rhee","year":"2005","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.autrev.2023.103486_bb1120","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-033880","article-title":"Meta-analysis of anti-Saccharomyces cerevisiae antibodies as diagnostic markers of Behcet's disease with gastrointestinal involvement","volume":"10","author":"Cheng","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.autrev.2023.103486_bb1125","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/cei.12328","article-title":"Diagnostic potential of antibody titres against Candida cell wall beta-glucan in Kawasaki disease","volume":"177","author":"Ishibashi","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2023.103486_bb1130","first-page":"49","article-title":"Gastrointestinal-associated autoantibodies in different autoimmune diseases","volume":"1","author":"Shor","year":"2012","journal-title":"Am J Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2023.103486_bb1135","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00296-012-2431-3","article-title":"Anti-Saccharomyces cerevisiae antibodies in patients with systemic lupus erythematosus","volume":"33","author":"Mankai","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2023.103486_bb1140","doi-asserted-by":"crossref","first-page":"1149311","DOI":"10.3389\/fmicb.2023.1149311","article-title":"Fungal gut microbiota dysbiosis in systemic lupus erythematosus","volume":"14","author":"Yang","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.autrev.2023.103486_bb1145","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/07435800.2012.723293","article-title":"Anti-Saccharomyces cerevisiae antibodies are elevated in Graves' disease but not in Hashimoto's thyroiditis","volume":"38","author":"Mankai","year":"2013","journal-title":"Endocr Res"},{"key":"10.1016\/j.autrev.2023.103486_bb1150","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12020-010-9372-y","article-title":"Anti-Saccharomyces cerevisiae antibodies (ASCA) are elevated in autoimmune thyroid disease ASCA in autoimmune thyroid disease","volume":"38","author":"Yazici","year":"2010","journal-title":"Endocrine"},{"issue":"Suppl. 112","key":"10.1016\/j.autrev.2023.103486_bb1155","first-page":"73","article-title":"Prevalence and significance of anti-Saccharomyces cerevisiae antibodies in primary Sjogren\u2019s syndrome","volume":"36","author":"Alunno","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2023.103486_bb1160","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/odi.12896","article-title":"Oral yeast colonization in patients with primary and secondary Sjogren's syndrome","volume":"24","author":"Medeiros","year":"2018","journal-title":"Oral Dis"},{"key":"10.1016\/j.autrev.2023.103486_bb1165","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00296-010-1722-9","article-title":"Anti-Saccharomyces cerevisiae (ASCA) and anti-endomysial antibodies in spondyloarthritis","volume":"32","author":"Andretta","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2023.103486_bb1170","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jbspin.2015.10.011","article-title":"Anti-Saccharomyces cerevisiae antibodies (ASCA) in spondyloarthritis: prevalence and associated phenotype","volume":"83","author":"Maillet","year":"2016","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2023.103486_bb1175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2021.105245","article-title":"Contribution of mycobiota to the pathogenesis of spondyloarthritis","volume":"88","author":"Berthelot","year":"2021","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2023.103486_bb1180","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s12022-010-9118-7","article-title":"Anti-Saccharomyces cerevisiae antibodies are frequent in type 1 diabetes","volume":"21","author":"Sakly","year":"2010","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.autrev.2023.103486_bb1185","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109189","article-title":"Women with type 1 diabetes exhibit a progressive increase in gut Saccharomyces cerevisiae in pregnancy associated with evidence of gut inflammation","volume":"184","author":"Bandala-Sanchez","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.autrev.2023.103486_bb1190","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s42003-023-04591-x","article-title":"Abnormal proliferation of gut mycobiota contributes to the aggravation of type 2 diabetes","volume":"6","author":"Bao","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.autrev.2023.103486_bb1195","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40608-017-0164-2","article-title":"Anti-Saccharomyces cerevisiae antibodies (ASCA) are associated with body fat mass and systemic inflammation, but not with dietary yeast consumption: a cross-sectional study","volume":"4","author":"Kvehaugen","year":"2017","journal-title":"BMC Obes"},{"key":"10.1016\/j.autrev.2023.103486_bb1200","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/cob.12079","article-title":"Baker\u2019s yeast (Saccharomyces cerevisiae) antigen in obese and normal weight subjects","volume":"5","author":"Salamati","year":"2015","journal-title":"Clin Obes"},{"key":"10.1016\/j.autrev.2023.103486_bb1205","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2310\/6650.2007.00024","article-title":"Anti-Saccharomyces cerevisiae antibodies in acute myocardial infarction","volume":"55","author":"Cinemre","year":"2007","journal-title":"J Invest Med"},{"key":"10.1016\/j.autrev.2023.103486_bb1210","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1111\/ene.15711","article-title":"Elevated serum anti-Saccharomyces cerevisiae antibody accompanied by gut mycobiota dysbiosis as a biomarker of diagnosis in patients with de novo Parkinson disease","volume":"11","author":"Chen","year":"2023","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.autrev.2023.103486_bb1215","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3233\/JPD-202237","article-title":"The gut mycobiome in Parkinson\u2019s disease","volume":"11","author":"Cirstea","year":"2021","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.autrev.2023.103486_bb1220","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3389\/fpsyt.2018.00627","article-title":"Anti-Candida albicans IgG antibodies in children with autism spectrum disorders","volume":"9","author":"Hughes","year":"2018","journal-title":"Front Psych"},{"key":"10.1016\/j.autrev.2023.103486_bb1225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.33588\/rn.6801.2018129","article-title":"Candida spp. in the gut microbiota of people with autism: a systematic review","volume":"68","author":"Andreo-Martinez","year":"2019","journal-title":"Rev Neurol"},{"key":"10.1016\/j.autrev.2023.103486_bb1230","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40168-017-0242-1","article-title":"New evidences on the altered gut microbiota in autism spectrum disorders","volume":"5","author":"Strati","year":"2017","journal-title":"Microbiome"},{"key":"10.1016\/j.autrev.2023.103486_bb1235","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10803-020-04543-y","article-title":"Dysbiosis of gut fungal microbiota in children with autism spectrum disorders","volume":"51","author":"Zou","year":"2021","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.autrev.2023.103486_bb1240","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.psychres.2017.05.005","article-title":"The association between immune markers and recent suicide attempts in patients with serious mental illness: a pilot study","volume":"255","author":"Dickerson","year":"2017","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.autrev.2023.103486_bb1245","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jad.2023.03.086","article-title":"Altered gut bacterial-fungal interkingdom networks in children and adolescents with depression","volume":"332","author":"Hao","year":"2023","journal-title":"J Affect Disord"},{"key":"10.1016\/j.autrev.2023.103486_bb1250","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.schres.2019.01.007","article-title":"Gut permeability and mimicry of the glutamate ionotropic receptor NMDA type subunit associated with protein 1 (GRINA) as potential mechanisms related to a subgroup of people with schizophrenia with elevated antigliadin antibodies (AGA IgG)","volume":"208","author":"Cihakova","year":"2019","journal-title":"Schizophr Res"},{"key":"10.1016\/j.autrev.2023.103486_bb1255","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.schres.2012.02.025","article-title":"Gastrointestinal inflammation and associated immune activation in schizophrenia","volume":"138","author":"Severance","year":"2012","journal-title":"Schizophr Res"},{"key":"10.1016\/j.autrev.2023.103486_bb1260","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.3390\/jcm9113707","article-title":"The differences between gluten sensitivity, intestinal biomarkers and immune biomarkers in patients with first-episode and chronic schizophrenia","volume":"9","author":"Dzikowski","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2023.103486_bb1265","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.schres.2022.10.011","article-title":"Gut mycobiota dysbiosis in drug-naive, first-episode schizophrenia","volume":"250","author":"Yuan","year":"2022","journal-title":"Schizophr Res"},{"key":"10.1016\/j.autrev.2023.103486_bb1270","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbi.2016.11.019","article-title":"Probiotic normalization of Candida albicans in schizophrenia: a randomized, placebo-controlled, longitudinal pilot study","volume":"62","author":"Severance","year":"2017","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.autrev.2023.103486_bb1275","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/bdi.12159","article-title":"Seroreactive marker for inflammatory bowel disease and associations with antibodies to dietary proteins in bipolar disorder","volume":"16","author":"Severance","year":"2014","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.autrev.2023.103486_bb1280","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/cts.12953","article-title":"SARS-CoV-2 infection as a trigger of autoimmune response","volume":"14","author":"Sacchi","year":"2021","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.autrev.2023.103486_bb1285","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ajg.2022.07.001","article-title":"Anti-Saccharomyces cerevisiae antibodies in patients with COVID-19","volume":"23","author":"Melayah","year":"2022","journal-title":"Arab J Gastroenterol"},{"key":"10.1016\/j.autrev.2023.103486_bb1290","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1053\/j.gastro.2020.06.048","article-title":"Alterations in fecal fungal microbiome of patients with COVID-19 during time of hospitalization until discharge","volume":"159","author":"Zuo","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2023.103486_bb1295","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41586-019-1608-2","article-title":"The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL","volume":"574","author":"Aykut","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2023.103486_bb1300","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1038\/s41586-023-06292-1","article-title":"Revisiting the intrinsic mycobiome in pancreatic cancer","volume":"620","author":"Fletcher","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2023.103486_bb1305","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188489","article-title":"Gut mycobiome: a promising target for colorectal cancer","volume":"1875","author":"Qin","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223002203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223002203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:29:53Z","timestamp":1761600593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997223002203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":261,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1568997223002203"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103486","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From ASCA breakthrough in Crohn's disease and Candida albicans research to thirty years of investigations about their meaning in human health","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103486","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103486"}}